Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Telomir Pharmaceuticals, Inc. (TELO) had Free Cash Flow of $-3.69M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-2.06M |
|
-- |
|
-- |
|
$2.13M |
|
$-2.13M |
|
$0.07M |
|
$-2.06M |
|
$-2.06M |
|
$-2.06M |
|
$-2.06M |
|
$-2.06M |
|
$-2.06M |
|
$-2.13M |
|
$-2.13M |
|
31.65M |
|
31.65M |
|
$-0.06 |
|
$-0.06 |
|
| Balance Sheet Financials | |
$7.34M |
|
-- |
|
-- |
|
$7.34M |
|
$1.43M |
|
-- |
|
-- |
|
$1.43M |
|
$5.91M |
|
$5.91M |
|
$5.91M |
|
34.38M |
|
| Cash Flow Statement Financials | |
$-3.69M |
|
-- |
|
$9.71M |
|
$1.27M |
|
$7.29M |
|
$6.02M |
|
$5.29M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Free Cash Flow |
$-3.69M |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-34.86% |
|
-34.86% |
|
-28.08% |
|
-34.86% |
|
$0.17 |
|
$-0.12 |
|
$-0.12 |
|